Navigation Links
Amicus Therapeutics Opens Research Facility in San Diego
Date:9/15/2008

CRANBURY, N.J. and SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, today announced that the company has leased laboratory space for a focused, small scale research facility in San Diego. The facility will be used to support ongoing research into new applications of the company's platform technology.

"With proof of concept for pharmacological chaperones now established, research at the San Diego facility will support Amicus' efforts to expand our early stage pipeline," said David Lockhart, Ph.D., chief scientific officer for Amicus Therapeutics. "Locating the new laboratory in San Diego allows us to complement and expand our existing research capabilities in Cranbury by tapping into the significant resources and expertise of the San Diego science and biotechnology community."

"We believe pharmacological chaperones have significant potential to treat a broad range of genetic diseases," added John Crowley, president and CEO of Amicus. "The focus of our research efforts in San Diego will be to assess new chaperone applications in diseases with high unmet medical needs and larger patient populations particularly in the areas of neurodegenerative and metabolic disorders. This small scale facility will complement our core research and development activities in New Jersey."

The new laboratory space was included in Amicus' operating plan and budget for 2008 as part of increased investment in research beyond the lysosomal storage disorders. Amicus expects to begin occupying the space immediately.

About Amicus Therapeutics

Amicus Therape
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ewswire/ -- The Michael J. Fox Foundation for Park...on in total awards to six research teams working t...for Parkinson,s disease. The funding was awarded u...arkinson,s Disease program, made possible by fund...euroscience-based biotechnology company. ,, Th...
(Date:11/30/2009).... Jessica Torrente, Assistant Professor of Radiolo...in Washington, D.C., demonstrated the integration ... clinical practice as an adjunct imaging modality ...nual meeting of the Radiological Society of North ...was to demonstrate how BSGI is used in the clinica...
(Date:11/30/2009)...viding smart and efficient software to the preclin...volutionizing work-from-home histopathology by uti...re used by 8 of the Top 10 Pharmaceutical Companie...uo; basis. , Mount Arling...nced another evolution in the histopathology realm...
(Date:11/30/2009)...PRNewswire/ -- ApaTech, the rapidly growing,orthob...ng,Biotech/Pharmaceutical/Medical Technology/Equip...500 for EMEA (Europe, Middle East and Africa). ,...s, five-year revenue growth,for which ApaTech has...achievement places ApaTech 9th overall in the rank...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
... Corporation,(Nasdaq: BPUR ) today announced that... Healthcare Products Regulatory Agency (MHRA) is s... of the meeting is to clarify the issues outlined ...e United Kingdom,s Commission,on Human Medicines r...uthorization for Hemopure(R). The issues relate to...
...red Hutchinson Cancer,Research Center have a lead ... the first systematic surveillance program of men ...to help determine when to wait and when,to treat t...y Foundation,and the National Cancer Institute., ...nical Research and,Human Biology divisions, will l...
...mployees were recognized,for their significant con...nnual TWIN Awards Dinner held May 1, 2008. Honored...ncology, Drug Regulatory Affairs, and Sherrie,Piet...mistry., "These individuals exemplify the best an...ontributions to the company,s success, and to the ...
Other Biology Technology:Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 2Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 3When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 2When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 3Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 2Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 3
(Date:11/30/2009)...ion rates and register online now for the premiere...co-ecceo10.org/ , WHAT: IOF WCO-ECCEO10 is a j...undation (IOF) and the European Society for Clinic...rthritis (ESCEO). More than 5,000 participants fro...iting scientific programme includes 12 plenary ses...
(Date:11/30/2009)... Neurotechnology ( http://www.neur...ometric identification technologies, has released ...e: VeriLook 4.0 Software Development Kit (SDK) f...r large-scale multi-biometric and automated finger...bilities in VeriLook 4.0 provide enhanced facial r...
(Date:11/26/2009)...using recordings of birdsong to accurately measure...ime sound recordings from a microphone array have ...ecies, populations. Because the new technique, rep... of Applied Ecology , will also work with whale so...y to monitor whale and dolphin numbers. , Develo...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Ecologists sound out new solution for monitoring cryptic species 2Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30 2009 52273 1Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30 2009 52273 2Smart Ideas at the Intersection of Transportation Health and Equity 52268 1Smart Ideas at the Intersection of Transportation Health and Equity 52268 2Smart Ideas at the Intersection of Transportation Health and Equity 52268 3Smart Ideas at the Intersection of Transportation Health and Equity 52268 4New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 1New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 2New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 3
...searchers at Jefferson Medical College and the Kim...n Philadelphia and at the Albert Einstein College ...ting that a mutation in a gene that normally helps... role in the initiation of a major form of breast ... P. Lisanti, M.D., Ph.D., professor of cancer biol...
...om dental implants to hip replacements, biomateria...ng this modern medical revolution share a basic ch...on the lab bench actually work inside the human bo...er an inflammatory response? And can that material... such questions, researchers at the National Insti...
...ansplantation of hematopoietic stem cells (HSCs, t...immune cell types) can save patients whose own hem...ed (often through radiation or chemotherapy of can...obtain enough of them for a successful transplant....colleagues have developed a way to expand HSCs in ...
Other Biology News:Jefferson scientists identify gene mutation potentially involved in breast cancer initiation 2Jefferson scientists identify gene mutation potentially involved in breast cancer initiation 3Finding the right mix: A biomaterial blend library 2Stem cell expansion 2
Phosphate Colorimetric Assay Kit, PiBlue™ from BioAssay Systems
Phosphate Colorimetric Assay Kit from BioAssay Systems
Varian 1200L GC/MS from Varian, Inc.
EnzChek cellulase substrate *blue fluorescent, 339/452 from Invitrogen
Biology Products: